Cargando…

Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles

Extracellular vesicles (EVs) have emerged as a promising platform for gene delivery owing to their natural properties and phenomenal functions, being able to circumvent the significant challenges associated with toxicity, problematic biocompatibility, and immunogenicity of the standard approaches. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaowen, Li, Aifang, Xu, Peng, Yu, Yangfan, Li, Shuxuan, Hu, Lina, Feng, Shuying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249948/ https://www.ncbi.nlm.nih.gov/pubmed/37291577 http://dx.doi.org/10.1186/s12951-023-01952-w

Ejemplares similares

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
por: Feng, Shuying, et al.
Publicado: (2022)

CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
por: Lu, Yaoyao, et al.
Publicado: (2023)

A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
por: Feng, Shuying, et al.
Publicado: (2023)

CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
por: Horodecka, Katarzyna, et al.
Publicado: (2021)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
por: Zhu, Xinglong, et al.
Publicado: (2023)

Recent Advances in CRISPR/Cas9 Delivery Strategies
por: Yip, Bon Ham
Publicado: (2020)

CRISPR/Cas9-induced β-carotene hydroxylase mutation in Dunaliella salina CCAP19/18
por: Hu, Lina, et al.
Publicado: (2021)

Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2023)

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
por: Liu, Xiao, et al.
Publicado: (2023)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
por: Montagna, Claudia, et al.
Publicado: (2018)

Editorial: Current approaches to CRISPR/Cas9 delivery
por: Uludağ, Hasan, et al.
Publicado: (2022)

Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
por: Massaro, Crescenzo, et al.
Publicado: (2020)

In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System
por: Ye, Yangyang, et al.
Publicado: (2022)

Current advances of CRISPR-Cas technology in cell therapy
por: Qiu, Hou-Yuan, et al.
Publicado: (2022)

Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
por: Li, Tianwen, et al.
Publicado: (2023)

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems
por: Hejabi, Faranak, et al.
Publicado: (2022)

Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
por: Caprifico, Anna E., et al.
Publicado: (2022)

Regulating the production and biological function of small extracellular vesicles: current strategies, applications and prospects
por: Luo, Lei, et al.
Publicado: (2021)

Can egg yolk antibodies terminate the CSBV infection in apiculture?
por: Li, Aifang, et al.
Publicado: (2023)

CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles
por: Hong, Jae‐Sang, et al.
Publicado: (2023)

Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
por: Zhuang, Jialang, et al.
Publicado: (2020)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Current and Prospective Applications of CRISPR-Cas12a in Pluricellular Organisms
por: Khan, Shaheen, et al.
Publicado: (2022)

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
por: Lu, Xinyue, et al.
Publicado: (2023)

An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification
por: Xing, Shan, et al.
Publicado: (2020)

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023)

CRISPR/Cas9 therapeutics: progress and prospects
por: Li, Tianxiang, et al.
Publicado: (2023)

The Obstacles to Current Extracellular Vesicle-Mediated Drug Delivery Research
por: Lee, Heedoo, et al.
Publicado: (2017)

Biomaterials and Extracellular Vesicle Delivery: Current Status, Applications and Challenges
por: Leung, Kasey S., et al.
Publicado: (2022)

CRISPR/Cas systems: Delivery and application in gene therapy
por: Huang, Jie, et al.
Publicado: (2022)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)

Improving Horticultural Crops via CRISPR/Cas9: Current Successes and Prospects
por: Bhatta, Bed Prakash, et al.
Publicado: (2020)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects
por: Dai, Zhanqiu, et al.
Publicado: (2022)

Advances of engineered extracellular vesicles-based therapeutics strategy
por: Komuro, Hiroaki, et al.
Publicado: (2022)

Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing
por: Yao, Xingang, et al.
Publicado: (2021)

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
por: Lohia, Aayushi, et al.
Publicado: (2022)

Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery
por: Rodríguez, Diego A., et al.
Publicado: (2022)

CRISPR/Cas9 Genome Editing vs. Over-Expression for Fluorescent Extracellular Vesicle-Labeling: A Quantitative Analysis
por: Strohmeier, Karin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ehupeoftfkbgqka5ptme5q3qer